Φορτώνει......
Co-targeting cancer stem-like cells and bulk cancer cells with a bispecific antibody
Epidermal growth factor receptor (EGFR) is a widely recognized target for tumors, but resistance is commonly reported. Recently, we reported that dual targeting of EGFR and NOTCH2/3 receptors with antibody CT16 showed a strong anti-stem effect both in vitro and in vivo to overcome resistance of EGFR...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mol Cell Oncol |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5462514/ https://ncbi.nlm.nih.gov/pubmed/28616585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2017.1308851 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|